The Journal of Antibiotics
Online ISSN : 1881-1469
Print ISSN : 0021-8820
ISSN-L : 0021-8820
FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002
II. Biological Properties and Mode of Action
MOTOO KOBAYASHIIKUKO SATOFUMIE ABEKUMIKO NITTAMICHIZANE HASHIMOTOAKIHIKO FUJIEMOTOHIRO HINOYASUHIRO HORI
著者情報
ジャーナル フリー

2004 年 57 巻 12 号 p. 788-796

詳細
抄録

FR227244 is a novel triterpene glycoside that exhibits in vitro antifungal activity against filamentous fungi such as Aspergillus sp. and Trichophyton sp. and yeast such as Candida utilis and Candida parapsilosis but shows low activity against Candida albicans, Candida krusei and Candida tropicalis. Specifically, FR227244 exhibits in vitro and in vivo antifungal activity against Aspergillus fumigatus. The minimum effective concentration (MEC) of FR227244 against A. fumigatus FP1305 in a micro-broth dilution test was 0.031μg/ml. FR227244 showed good efficacy by subcutaneous injection and oral administration against A. fumigatus in a murine systemic infection model, with ED50s of 1.9 and 18mg/kg, respectively. FR227244 inhibited glucan synthesis in a 1, 3-β-glucan synthase assay weakly and in whole cells strongly, but did not effect other macromolecule synthesis, including protein, nucleic acids, mannan and chitin. These results and the effect on hyphal morphology of A. fumigatus suggested that FR227244 showed antifungal activity based on inhibition of glucan synthesis.

著者関連情報
© Japan Antibiotics Research Association
前の記事 次の記事
feedback
Top